Fig. 2
Cancer by complementation group and phenotype. Cancer is less common among XP-CS patients than in the XP population without CS. Red: XP-G. Blue: XP-D
Fig. 2 | Orphanet Journal of Rare Diseases
Cancer by complementation group and phenotype. Cancer is less common among XP-CS patients than in the XP population without CS. Red: XP-G. Blue: XP-D
Orphanet Journal of Rare Diseases